Answers are grounded in this paper and cite their sources.
Dual isotope SPECT imaging can provide individualized tumor dose-responses that can be used to predict lutetium-177 treatment efficacy. This bio-dosimeter metric appears to be dependent upon the extent of senescence induction and suggests an integral role that senescence plays in lutetium-177 treatment efficacy.
No takes yet. Share an insight, caveat, or question.
O’Neill et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: